McIlrath & Eck’s ResMed RMD Stock Holding History

McIlrath & Eck’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-210	Closed	-$48K	–	994
2024 Q4	$48K	Buy	210 +171	+438%	+$41.2K	0.01%	318
2024 Q3	$9.52K	Buy	+39	New	+$8.71K	﹤0.01%	634

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

McIlrath & Eck's RMD Position: Q1 2025 in Review

McIlrath & Eck sold out of ResMed (RMD) in Q1 2025, closing a stake of 210 shares — an estimated $48K sold.

McIlrath & Eck first reported a position in RMD in Q3 2024 and held it in 2 quarters. The position peaked at $48K in Q4 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

McIlrath & Eck reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
McIlrath & Eck sold 210 ResMed shares in Q1 2025, an estimated $48K.
McIlrath & Eck first reported a position in ResMed in Q3 2024 and held it in 2 quarters.
McIlrath & Eck's ResMed position peaked at $48K in Q4 2024.
885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on McIlrath & Eck's 13F filing for Q1 2025, filed 16 May 2025.